Klosterneuburg, Austria

Andreas Wagner

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andreas Wagner: Innovator in RNA Nanoparticle Technology

Introduction

Andreas Wagner is a notable inventor based in Klosterneuburg, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of lipid-encapsulated RNA nanoparticles. His innovative approach has the potential to advance therapeutic applications in medicine.

Latest Patents

Wagner holds a patent for a method of making lipid-encapsulated RNA nanoparticles. This patent outlines a process that involves flowing an aqueous solution containing RNA through a tube, while simultaneously introducing a lipid-containing ethanol solution through a second tube. The mixing of these solutions results in a turbulent flow that produces lipid-encapsulated RNA nanoparticles with a bilayer structure. This method is crucial for enhancing the delivery and efficacy of RNA-based therapies.

Career Highlights

Andreas Wagner is currently associated with Arcturus Therapeutics, Inc., where he continues to work on innovative solutions in the field of RNA technology. His expertise and dedication to research have positioned him as a key figure in the development of advanced therapeutic methods.

Collaborations

Wagner collaborates with talented professionals in his field, including Priya Prakash Karmali and Padmanabh Chivukula. These collaborations enhance the research and development efforts at Arcturus Therapeutics, Inc., fostering innovation and progress in RNA nanoparticle technology.

Conclusion

Andreas Wagner's contributions to the field of RNA nanoparticle technology exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific understanding but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…